Literature DB >> 32808450

CircPSMC3 alleviates the symptoms of PCOS by sponging miR-296-3p and regulating PTEN expression.

Jun Liu1,2, Jinli Ding1, Bing Qu1, Jiuying Liu2, Xiaojie Song2, Qingli Suo2, Aifen Zhou2, Jing Yang1.   

Abstract

Polycystic ovary syndrome (PCOS), the most common female endocrine disease that causes anovulatory infertility, still lacks promising strategy for the accurate diagnosis and effective therapeutics of PCOS attributed to its unclear aetiology. In this study, we determined the abnormal reduction in circPSMC3 expression by comparing the ovarian tissue samples of PCOS patients and normal individuals. The symptom relief caused by up-regulation of circPSMC3 in PCOS model mice suggested the potential for further study. In vitro functional experiments confirmed that circPSMC3 can inhibit cell proliferation and promote apoptosis by blocking the cell cycle in human-like granular tumour cell lines. Mechanism study revealed that circPSMC3 may play its role through sponging miR-296-3p to regulate PTEN expression. Collectively, we preliminarily characterized the role and possible insights of circPSMC3/miR-296-3p/PTEN axis in the proliferation and apoptosis of KGN cells. We hope that this work provides some original and valuable information for the research of circRNAs in PCOS, not only to better understand the pathogenesis but also to help provide new clues for seeking for the future therapeutic target of PCOS.
© 2020 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd.

Entities:  

Keywords:  CircPSMC3; KGN cells; PCOS; PTEN; miR-296-3p

Mesh:

Substances:

Year:  2020        PMID: 32808450      PMCID: PMC7521274          DOI: 10.1111/jcmm.15747

Source DB:  PubMed          Journal:  J Cell Mol Med        ISSN: 1582-1838            Impact factor:   5.295


  58 in total

Review 1.  CLINICAL PRACTICE. Polycystic Ovary Syndrome.

Authors:  Christopher R McCartney; John C Marshall
Journal:  N Engl J Med       Date:  2016-07-07       Impact factor: 91.245

2.  MicroRNA-135a Regulates VEGFC Expression and Promotes Luteinized Granulosa Cell Apoptosis in Polycystic Ovary Syndrome.

Authors:  Yifang Wei; Shenglian Lu; Yu Hu; Li Guo; Xiaoyu Wu; Xing Liu; Yun Sun
Journal:  Reprod Sci       Date:  2020-02-03       Impact factor: 3.060

Review 3.  MicroRNAs expressed in neuronal differentiation and their associated pathways: Systematic review and bioinformatics analysis.

Authors:  Roberta Giorgi Silveira; Camila Perelló Ferrúa; Cainá Corrêa do Amaral; Tiago Fernandez Garcia; Karoline Brizola de Souza; Fernanda Nedel
Journal:  Brain Res Bull       Date:  2020-01-13       Impact factor: 4.077

4.  Molecular biology. A circuitous route to noncoding RNA.

Authors:  Jeremy E Wilusz; Phillip A Sharp
Journal:  Science       Date:  2013-04-26       Impact factor: 47.728

5.  MiR-296-3p regulates cell growth and multi-drug resistance of human glioblastoma by targeting ether-à-go-go (EAG1).

Authors:  Yifeng Bai; Hongzhan Liao; Tianzhu Liu; Xiangping Zeng; Faman Xiao; Luqiao Luo; Hongbo Guo; Linlang Guo
Journal:  Eur J Cancer       Date:  2012-09-18       Impact factor: 9.162

6.  Iridoids with Genipin Stem Nucleus Inhibit Lipopolysaccharide-Induced Inflammation and Oxidative Stress by Blocking the NF-κB Pathway in Polycystic Ovary Syndrome.

Authors:  Tao Zuo; Minghui Zhu; Wenming Xu; Zhixia Wang; Hang Song
Journal:  Cell Physiol Biochem       Date:  2017-10-19

Review 7.  MicroRNAs--micro in size but macro in function.

Authors:  Sunit K Singh; Manika Pal Bhadra; Hermann J Girschick; Utpal Bhadra
Journal:  FEBS J       Date:  2008-08-27       Impact factor: 5.542

8.  Circular RNA expression profiling of granulosa cells in women of reproductive age with polycystic ovary syndrome.

Authors:  Chunren Zhang; Jianqiao Liu; Maohua Lai; Juan Li; Jiahui Zhan; Qidan Wen; Hongxia Ma
Journal:  Arch Gynecol Obstet       Date:  2019-04-01       Impact factor: 2.344

Review 9.  Tumor-suppressive circular RNAs: Mechanisms underlying their suppression of tumor occurrence and use as therapeutic targets.

Authors:  Zhe Li; Yao Ruan; Haiyan Zhang; Yijing Shen; Tianwen Li; Bingxiu Xiao
Journal:  Cancer Sci       Date:  2019-10-25       Impact factor: 6.716

Review 10.  circ-016910 sponges miR-574-5p to regulate cell physiology and milk synthesis via MAPK and PI3K/AKT-mTOR pathways in GMECs.

Authors:  Yuhan Liu; Jinxing Hou; Meng Zhang; Emeline Seleh-Zo; Jiangang Wang; Binyun Cao; Xiaopeng An
Journal:  J Cell Physiol       Date:  2019-10-29       Impact factor: 6.384

View more
  9 in total

Review 1.  The emerging roles and potential applications of circular RNAs in ovarian cancer: a comprehensive review.

Authors:  Sajad Najafi
Journal:  J Cancer Res Clin Oncol       Date:  2022-09-02       Impact factor: 4.322

2.  Clinical study on polycystic ovary syndrome treated with Diane-35 and Pioglitazone.

Authors:  Chunjing Cao; Yuanyuan Qi; Dongmei Fang; Yan Yu
Journal:  Am J Transl Res       Date:  2021-11-15       Impact factor: 4.060

3.  WGCNA Analysis Identifies Polycystic Ovary Syndrome-Associated Circular RNAs That Interact with RNA-Binding Proteins and Sponge miRNAs.

Authors:  Mengxiong Li; Zhi Zeng; Aiqing Zhang; Qingjian Ye; Shujun Su; Tingting Xia
Journal:  Int J Gen Med       Date:  2021-11-23

4.  Circular RNA circ_RANBP9 exacerbates polycystic ovary syndrome via microRNA-136-5p/XIAP axis.

Authors:  Xiaohui Lu; Haijie Gao; Bo Zhu; Guilan Lin
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

Review 5.  MicroRNAs in obesity, sarcopenia, and commonalities for sarcopenic obesity: a systematic review.

Authors:  Lisa Dowling; Ankita Duseja; Tatiane Vilaca; Jennifer S Walsh; Katarzyna Goljanek-Whysall
Journal:  J Cachexia Sarcopenia Muscle       Date:  2022-01-04       Impact factor: 12.910

6.  The circular RNA circ_0030018/miR-136/migration and invasion enhancer 1 (MIEN1) axis promotes the progression of polycystic ovary syndrome.

Authors:  Jing Xu; Qinghua Qu; Bao Liu; Liyuan Shen
Journal:  Bioengineered       Date:  2022-03       Impact factor: 3.269

7.  A machine-learning approach for predicting the effect of carnitine supplementation on body weight in patients with polycystic ovary syndrome.

Authors:  Dong-Dong Wang; Ya-Feng Li; Yi-Zhen Mao; Su-Mei He; Ping Zhu; Qun-Li Wei
Journal:  Front Nutr       Date:  2022-08-10

8.  The complex metabolic interactions of liver tissue and hepatic exosome in PCOS mice at young and middle age.

Authors:  ShanHu Gao; Fei Long; Zheng Jiang; Jun Shi; DongXue Ma; Yang Yang; Jin Bai; Ting-Li Han
Journal:  Front Physiol       Date:  2022-09-20       Impact factor: 4.755

9.  CircPSMC3 alleviates the symptoms of PCOS by sponging miR-296-3p and regulating PTEN expression.

Authors:  Jun Liu; Jinli Ding; Bing Qu; Jiuying Liu; Xiaojie Song; Qingli Suo; Aifen Zhou; Jing Yang
Journal:  J Cell Mol Med       Date:  2020-08-17       Impact factor: 5.295

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.